Business Wire20d
New Data for AREXVY, GSK’s Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease
PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced new preliminary data for AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) in adults aged 18-49 at increased risk for ...
Kaleido Scope2y
SCI Fact Sheets
The UAB-SCIMS offers a series of Fact Sheets on selected topics related to SCI. Some Fact Sheets are products of the University of Alabama at Birmingham Spinal Cord Injury Model System (UAB-SCIMS).
GSK Arexvy protects from RSV over three full seasons
Based on data from its AReSVi-006 trial, the British vaccine maker said Arexvy, compared to a placebo, led to an overall ...
Canada approves GSK's RSV vaccine for adults aged 50 to 59
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...
Business Insider20d
GSK reports preliminary data for AREXVY
GSK (GSK) announced new preliminary data for AREXVY in adults aged 18-49 at increased risk for lower respiratory tract disease, LRTD, caused by respiratory syncytial virus due to certain ...
insider.si.edu6mon
Early Cars: Fact Sheet for Children
Who made the first cars? Beginning in the 1770s, many people tried to make cars that would run on steam. Some early steam cars worked well, and some did not. Some were fire pumpers that moved by ...
GSK Q3 Earnings Preview: Shingrix And Arexvy Make The Stock A 'Strong Buy'
GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...
McKnight's Long-Term Care News1mon
RSV vaccine still 43.3 percent effective 3 years after people take it, trial shows
GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% effective in preventing severe illness three years after patients 60 and older ...
Yahoo Finance14d
GSK sales hampered by slump in demand for key vaccine
Drugmaker GSK saw a sharp drop in revenue from its blockbuster Arexvy vaccine in the third quarter, dampening overall sales growth. Sales of the jab for respiratory syncytial virus (RSV ...
Investopedia23d
The Federal Reserve Balance Sheet Explained
Yarilet Perez is an experienced multimedia journalist and fact-checker with a Master of ... The Fed uses its balance sheet to help it accomplish those goals. The Fed decides what assets it holds ...
What I Wish I Knew About RSV in My Sixties
With the arrival of fall also comes the arrival of respiratory illness season, a time when many are at increased risk of ...
KARE 1128d
Daylight saving time: VERIFY Fact Sheet
People who live in states that observe daylight saving time will see more daylight in the mornings and darker evenings as we “fall back.” Many VERIFY readers have sent us questions about ...